Sevelamer Carbonate Articles
Impax Labs settles with Genzyme over Renvela and Renagel generics
5 September 2012
Genzyme’s woes continue as it drops investigational APB follow-up for Renvela, after poor trial results
19 November 2009
Third-quarter 2009 profit sinks at Genzyme, on production woes
22 October 2009
Genzyme sues Impax over Renvela patent
7 April 2009
Genzyme's Renvela gets nod for expanded EU label
30 March 2009
Genzyme's 2008 profit down on costs
23 February 2009
Genzyme's 3rd-qtr 2008 profit down 25%
3 November 2008
Genzyme's 2nd qtr profit hit by license cost
4 August 2008
Genzyme's 1st-qtr revenues jump 25%
5 May 2008
Genzyme debuts Renvela for US dialysis patients
10 March 2008
FDA approves Genzyme's Renvela
29 October 2007
Stock Commentary - New York week to July 9, 2007
16 July 2007
Stock Commentary - New York week to June 18, 2007
25 June 2007
Stock Commentary - New York week to June 4, 2007
11 June 2007
Stock Commentary - New York week to Jan 8, 2007
15 January 2007
Genzyme's 1st-qtr sales less than expected
1 May 2006
Showing 1-19 of 19 articles
- 1
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
